Prelude Capital Management, LLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Prelude Capital Management, LLC

  • $1.39 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021
SELL
$38.75 - $86.92 $499,875 - $1.12 Million
-12,900 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$34.61 - $123.66 $1.28 Million - $4.59 Million
-37,100 Reduced 74.2%
12,900 $560,000
Q3 2020

Nov 16, 2020
BUY
$37.49 - $63.19 $1.87 Million - $3.16 Million
50,000 New
50,000 $2.15 Million

Others Institutions Holding ARCT

# of Institutions
186
Shares Held
25.9M
Call Options Held
320K
Put Options Held
153K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $551M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email